DaVita DVA U S Dialysis And Related Lab Services — Goodwill
Discontinued — last reported Q4 '25
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DaVita in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: DaVita’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about DaVita's u s dialysis and related lab services — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is DaVita's u s dialysis and related lab services — goodwill?
- DaVita (DVA) reported u s dialysis and related lab services — goodwill of $6.53B in Q4 2025.
- How has DaVita's u s dialysis and related lab services — goodwill changed year-over-year?
- DaVita's u s dialysis and related lab services — goodwill increased by 0.2% year-over-year, from $6.52B to $6.53B.
- What is the long-term trend for DaVita's u s dialysis and related lab services — goodwill?
- Over 3 years (2021 to 2024), DaVita's u s dialysis and related lab services — goodwill has grown at a 0.9% compound annual growth rate (CAGR), from $25.35B to $26.07B.
- What does u s dialysis and related lab services — goodwill mean?
- The value of intangible assets like brand reputation and patient networks acquired through past business purchases in the U.S. dialysis segment.
- How do you interpret u s dialysis and related lab services — goodwill?
- An increase indicates recent acquisition activity, while a decrease suggests impairment charges or divestitures.
- How does u s dialysis and related lab services — goodwill compare across companies?
- Commonly reported as 'Goodwill' in segment-level disclosures for healthcare providers with active M&A strategies.